← Leaderboards
Xiang Chen
St. Jude Children'S Research Hospital
$2,994,809
Attributed
$4,353,459
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,353,459 · 2
By mechanism
R01$4,353,459 · 2
Top collaborators
- Jun Yang4 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Mark Edward Hatley$4,899,188
- Michael A Dyer$24,988,379
- Janet Anne Houghton$8,199,871
- James R Downing$3,840,185
- Madan Mohan$1,067,461
Others in their field
Other Rising Stars on “Innovation”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Mari Ostendorf · University Of Washington$51,931,230
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Cyrus Wadia · Activate Global, Inc.$31,489,493
Research focus
InnovationMalignant Childhood NeoplasmRhabdomyosarcomaPatient Derived Xenograft ModelTranscriptome SequencingMalignant NeoplasmsChromatinGenesIn VivoMolecularSingle-Cell Rna SequencingSoft TissueTumorCellsChemotherapyChildEpigenetic ProcessEpigenomicsGenetic TranscriptionEwings SarcomaBayesian AnalysisAdolescent13)(Q35Bar Codes
Grant awards (8)
EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA$691,425
R01 · FY2025 · CA
The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma$416,325
R01 · FY2025 · CA · contact PI
EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA$656,854
R01 · FY2024 · CA
The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma$395,510
R01 · FY2024 · CA · contact PI
EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA$677,596
R01 · FY2023 · CA
The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma$407,999
R01 · FY2023 · CA · contact PI
EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA$691,425
R01 · FY2022 · CA
The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma$416,325
R01 · FY2022 · CA · contact PI